Insider Transactions in Q2 2022 at Cue Biopharma, Inc. (CUE)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 14
2022
|
Cameron Gray Director |
SELL
Payment of exercise price or tax liability
|
Direct |
51,562
-6.98%
|
$154,686
$3.2 P/Share
|
|
Jun 14
2022
|
Cameron Gray Director |
BUY
Exercise of in-the-money or at-the-money derivatives securities
|
Direct |
61,111
+7.64%
|
$122,222
$2.7 P/Share
|
|
May 27
2022
|
Frank Morich |
BUY
Open market or private purchase
|
Direct |
28,000
+50.0%
|
$84,000
$3.75 P/Share
|
|
May 24
2022
|
Aaron G.L. Fletcher Director |
BUY
Open market or private purchase
|
Indirect |
55,000
+5.53%
|
$165,000
$3.34 P/Share
|
|
May 23
2022
|
Aaron G.L. Fletcher Director |
BUY
Open market or private purchase
|
Indirect |
150,000
+14.49%
|
$450,000
$3.52 P/Share
|